Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ) is now available.
Beijing Tong Ren Tang Chinese Medicine Co. reported its annual financial results for the year ending December 31, 2024. The company experienced a 5.7% increase in revenue to HK$1,611,644,000, but saw a decrease in profit for the year by 10.4% to HK$529,167,000. Despite the decline in profit, the company proposed a higher final dividend per share, indicating a commitment to returning value to shareholders. The results reflect challenges in managing costs and maintaining profitability amidst increased inventories and reduced cash balances.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co. is a company incorporated in Hong Kong, focusing on the Chinese medicine industry. It primarily deals with the production and distribution of traditional Chinese medicine products.
YTD Price Performance: -0.31%
Technical Sentiment Signal: Buy
Current Market Cap: $933.3M
See more data about 3613 stock on TipRanks’ Stock Analysis page.